We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Antigen Study Shows Promise for a Respiratory Syncytial Virus Vaccine

News   Mar 12, 2018 | Original Story by Tim Stephens for the university of California Santa Cruz.

 
Antigen Study Shows Promise for a Respiratory Syncytial Virus Vaccine

Immune system antibodies can block RSV infection and provide protection from RSV disease. This image shows how a protective human antibody (dark and light grey surface) sticks to a folded part of the RSV G protein antigen (rainbow colored blue-to-red). The new findings provide a foundation for the development of a RSV vaccine. Credit: Rebecca DuBois.

 
 
 

RELATED ARTICLES

Reflecting on Norovirus Outbreaks May Help Guide Vaccine Development

News

Study confirms several factors that can make norovirus outbreaks more severe and may help guide efforts to develop a vaccine to prevent this highly contagious disease.

READ MORE

Treatment for Canine Leishmaniasis Exists in Brazilian Vaccine

News

Canine leishmaniasis, typically transmitted by sand fly bites, can cause skin sores, weight loss, blindness and kidney failure.

READ MORE

'Bubble Baby' Study Calls for Neonatal Screening

News

As therapeutic options become more advanced, the case for neonatal screening strengthens.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE